| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1999;99:2118-2123.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
Expression of Endothelin-1, Endothelin-Converting Enzyme, and Endothelin Receptors in Chronic Heart Failure
From the Zentrum für Innere Medizin, Klinik III für Innere Medizin, Universität zu Köln, Cologne, Germany, and Biological Research Laboratories, Sankyo Co, Ltd, Tokyo, Japan (K.S., M.T.).
Correspondence to Michael Böhm, MD, Klinik III, Universität zu Köln, Joseph-Stelzmann-Straße 9, 50924 Köln, Germany. E-mail michael.boehm{at}medizin.uni-koeln.de
Background—Elevated plasma levels of endothelin (ET)-1 have been reported in association with heart diseases, including heart failure. Furthermore, it has been suggested that ET-1 acts as a local autocrine/paracrine factor with biological activities such as vasoconstriction, mitogenesis, and inotropic effects on the heart. This study investigated alterations of ET-1, ET receptor, and endothelin-converting enzyme (ECE) expression in left ventricular myocardium from patients with end-stage heart failure.
Methods and Results—mRNA concentrations of ETA and ETB receptors, prepro-ET-1 (ppET-1), and ECE in left ventricles from nonfailing donors hearts (NF) and from patients with end-stage chronic heart failure (NYHA functional class IV) due to dilated cardiomyopathy (DCM) were compared by use of a competitive reverse transcription–polymerase chain reaction technique. There was no significant difference in mRNA expression for ppET-1, ECE-1, and ETA receptors, whereas a significant reduction of ETB-receptor mRNA was observed in DCM hearts. 125I-labeled ET-1 radioligand binding studies demonstrated a significant downregulation of ETB receptors, whereas ETA-receptor density was increased in membranes from DCM hearts. Phosphoramidon-sensitive ECE activity and immunodetectable amounts of ECE protein in left ventricular membrane preparations did not differ between NF and DCM hearts. Finally, immunoreactive ET-1 concentrations were increased in DCM hearts.
Conclusions—The present study demonstrates changes in the ET-receptor expression pattern in favor of the ETA receptor in human end-stage heart failure. Furthermore, activation of the cardiac ET system with increased tissue ET-1 concentrations in the failing myocardium is observed. This is more likely due to decreased clearance than to increased synthesis, because ppET-1 gene expression and ECE activity are unchanged.
Key Words: endothelin • heart failure • enzymes • RNA • receptors
This article has been cited by other articles:
 |
|
 |
|
  W. B. Mathews, N. Murugesan, J. Xia, U. Scheffel, J. Hilton, H. T. Ravert, R. F. Dannals, and Z. Szabo Synthesis and In Vivo Evaluation of Novel PET Radioligands for Imaging the Endothelin-A Receptor J. Nucl. Med., September 1, 2008; 49(9): 1529 - 1536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. J. de Beer, O. Sorop, D. A. Pijnappels, D. H. Dekkers, F. Boomsma, J. M. J. Lamers, D. J. Duncker, and D. Merkus Integrative control of coronary resistance vessel tone by endothelin and angiotensin II is altered in swine with a recent myocardial infarction Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2069 - H2077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Y. Chung, M. Kang, and J. W. Walker Contractile regulation by overexpressed ETA requires intact T tubules in adult rat ventricular myocytes Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2391 - H2399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Pikkarainen, H. Tokola, R. Kerkela, M. Ilves, M. Makinen, H.-D. Orzechowski, M. Paul, O. Vuolteenaho, and H. Ruskoaho Inverse regulation of preproendothelin-1 and endothelin-converting enzyme-1beta genes in cardiac cells by mechanical load Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2006; 290(6): R1639 - R1645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Bredin and A. Franco-Cereceda Reversed remodelling in dilated cardiomyopathy by passive containment surgery is associated with decreased circulating levels of endothelin-1 Eur. J. Cardiothorac. Surg., March 1, 2006; 29(3): 299 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. V. Westfall, A. M. Lee, and D. A. Robinson Differential Contribution of Troponin I Phosphorylation Sites to the Endothelin-modulated Contractile Response J. Biol. Chem., December 16, 2005; 280(50): 41324 - 41331. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Munzel, U. Muhlhauser, W.-H. Zimmermann, M. Didie, K. Schneiderbanger, P. Schubert, S. Engmann, T. Eschenhagen, and O. Zolk Endothelin-1 and isoprenaline co-stimulation causes contractile failure which is partially reversed by MEK inhibition Cardiovasc Res, December 1, 2005; 68(3): 464 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Merkus, B. Houweling, A. H. van den Meiracker, F. Boomsma, and D. J. Duncker Contribution of endothelin to coronary vasomotor tone is abolished after myocardial infarction Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H871 - H880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Poelzl, M. Frick, H. Huegel, B. Lackner, H. F. Alber, J. Mair, M. Herold, S. Schwarzacher, O. Pachinger, and F. Weidinger Chronic heart failure is associated with vascular remodeling of the brachial artery Eur J Heart Fail, January 1, 2005; 7(1): 43 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Zolk, F. Munzel, and T. Eschenhagen Effects of chronic endothelin-1 stimulation on cardiac myocyte contractile function Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1248 - H1257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Parker and J. J. Thiessen Increased endothelin-1 production in patients with chronic heart failure Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1141 - H1145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Motte, R. van Beneden, J. Mottet, B. Rondelet, M. Mathieu, X. Havaux, P. Lause, C. Clercx, J.-M. Ketelslegers, R. Naeije, et al. Early activation of cardiac and renal endothelin systems in experimental heart failure Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2482 - H2491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. El-Armouche, O. Zolk, T. Rau, and T. Eschenhagen Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure Cardiovasc Res, December 1, 2003; 60(3): 478 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Kedzierski, P. A. Grayburn, Y. Y. Kisanuki, C. S. Williams, R. E. Hammer, J. A. Richardson, M. D. Schneider, and M. Yanagisawa Cardiomyocyte-Specific Endothelin A Receptor Knockout Mice Have Normal Cardiac Function and an Unaltered Hypertrophic Response to Angiotensin II and Isoproterenol Mol. Cell. Biol., November 15, 2003; 23(22): 8226 - 8232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rich and V. V. McLaughlin Endothelin Receptor Blockers in Cardiovascular Disease Circulation, November 4, 2003; 108(18): 2184 - 2190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Brutsaert Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity Physiol Rev, January 1, 2003; 83(1): 59 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Mittmann, C. H. Chung, G. Hoppner, C. Michalek, M. Nose, C. Schuler, A. Schuh, T. Eschenhagen, J. Weil, B. Pieske, et al. Expression of ten RGS proteins in human myocardium: functional characterization of an upregulation of RGS4 in heart failure Cardiovasc Res, September 1, 2002; 55(4): 778 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hurlimann, F. Ruschitzka, and T.F. Luscher The relationship between the endothelium and the vessel wall Eur. Heart J. Suppl., February 1, 2002; 4(suppl_A): A1 - A7. [Abstract] [PDF]
|
|
|
|
|
|
O. Zolk, J. Quattek, U. Seeland, A. El-Armouche, T. Eschenhagen, and M. Bohm Activation of the cardiac endothelin system in left ventricular hypertrophy before onset of heart failure in TG(mREN2)27 rats Cardiovasc Res, February 1, 2002; 53(2): 363 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. LEHRKE, R. WALDHERR, E. RITZ, and J. WAGNER Renal Endothelin-1 and Endothelin Receptor Type B Expression in Glomerular Diseases with Proteinuria J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2321 - 2329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-M. Herrmann, K. Schmidt-Petersen, J. Pfeifer, A. Perrot, N. Bit-Avragim, C. Eichhorn, R. Dietz, R. Kreutz, M. Paul, and K.J. Osterziel A polymorphism in the endothelin-A receptor gene predicts survival in patients with idiopathic dilated cardiomyopathy Eur. Heart J., October 2, 2001; 22(20): 1948 - 1953. [Abstract] [PDF]
|
|
|
|
|
|
S. Aleksic, Z. Szabo, U. Scheffel, H. T. Ravert, W. B. Mathews, L. Kerenyi, P. A. Rauseo, R. E. Gibson, H. D. Burns, and R. F. Dannals In Vivo Labeling of Endothelin Receptors with [11C]L-753,037: Studies in Mice and a Dog J. Nucl. Med., August 1, 2001; 42(8): 1274 - 1280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Spieker, G. Noll, F. T. Ruschitzka, and T. F. Luscher Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future? J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1493 - 1505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Berger, B. Stanek, M. Hulsmann, B. Frey, S. Heher, R. Pacher, and T. Neunteufl Effects of Endothelin A Receptor Blockade on Endothelial Function in Patients With Chronic Heart Failure Circulation, February 20, 2001; 103(7): 981 - 986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Morin, P. Paradis, A. Aries, and M. Nemer Serum Response Factor-GATA Ternary Complex Required for Nuclear Signaling by a G-Protein-Coupled Receptor Mol. Cell. Biol., February 15, 2001; 21(4): 1036 - 1044. [Abstract] [Full Text]
|
|
|
|
|
|
F. Duru, M. Barton, T. F. Luscher, and R. Candinas Endothelin and cardiac arrhythmias: do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs? Cardiovasc Res, February 1, 2001; 49(2): 272 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. F. Luscher and M. Barton Endothelins and Endothelin Receptor Antagonists : Therapeutic Considerations for a Novel Class of Cardiovascular Drugs Circulation, November 7, 2000; 102(19): 2434 - 2440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. L. Clark Perioperative Treatment of Congestive Heart Failure Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 2000; 4(4): 223 - 235. [Abstract] [PDF]
|
|
|
|
|
|
D. L. Moraes, W. S. Colucci, and M. M. Givertz Secondary Pulmonary Hypertension in Chronic Heart Failure : The Role of the Endothelium in Pathophysiology and Management Circulation, October 3, 2000; 102(14): 1718 - 1723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Rothermund, Y. M. Pinto, B. Hocher, R. Vetter, S. Leggewie, P. Ko{beta}mehl, H.-D. Orzechowski, R. Kreutz, and M. Paul Cardiac Endothelin System Impairs Left Ventricular Function in Renin-Dependent Hypertension via Decreased Sarcoplasmic Reticulum Ca2+ Uptake Circulation, September 26, 2000; 102(13): 1582 - 1588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Stangl, T. Dschietzig, C. Richter, M. Laule, V. Stangl, E. Tanis, G. Baumann, and S. B. Felix Pulmonary Release and Coronary and Peripheral Consumption of Big Endothelin and Endothelin-1 in Severe Heart Failure : Acute Effects of Vasodilator Therapy Circulation, September 5, 2000; 102(10): 1132 - 1138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Katz, K. Balidemaj, S. Homma, H. Wu, J. Wang, and S. Maybaum Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure J. Am. Coll. Cardiol., September 1, 2000; 36(3): 845 - 851. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P Love, C. J Ferro, W. G Haynes, C. Plumpton, A. P Davenport, D. J Webb, and J. J.V McMurray Endothelin receptor antagonism in patients with chronic heart failure Cardiovasc Res, July 1, 2000; 47(1): 166 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Zolk, P. Caroni, and M. Bohm Decreased Expression of the Cardiac LIM Domain Protein MLP in Chronic Human Heart Failure Circulation, June 13, 2000; 101(23): 2674 - 2677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Zolk and M. Bohm The role of the cardiac endothelin system in heart failure Nephrol. Dial. Transplant., June 1, 2000; 15(6): 758 - 760. [Full Text] [PDF]
|
|
|
|
|
|
A. Ergul, C. A. Walker, A. Goldberg, S. C. Baicu, J. W. Hendrick, M. K. King, and F. G. Spinale ET-1 in the myocardial interstitium: relation to myocyte ECE activity and expression Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H2050 - H2056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. G. N. Serneri, I. Cecioni, S. Vanni, R. Paniccia, B. Bandinelli, A. Vetere, X. Janming, I. Bertolozzi, M. Boddi, G. F. Lisi, et al. Selective Upregulation of Cardiac Endothelin System in Patients With Ischemic but Not Idiopathic Dilated Cardiomyopathy : Endothelin-1 System in the Human Failing Heart Circ. Res., March 3, 2000; 86(4): 377 - 385. [Abstract] [Full Text] [PDF]
|
|